These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase. Hou X; Arvisais EW; Davis JS Endocrinology; 2010 Jun; 151(6):2846-57. PubMed ID: 20351317 [TBL] [Abstract][Full Text] [Related]
8. 4EBP1/eIF4E and p70S6K/RPS6 axes play critical and distinct roles in hepatocarcinogenesis driven by AKT and N-Ras proto-oncogenes in mice. Wang C; Cigliano A; Jiang L; Li X; Fan B; Pilo MG; Liu Y; Gui B; Sini M; Smith JW; Dombrowski F; Calvisi DF; Evert M; Chen X Hepatology; 2015 Jan; 61(1):200-13. PubMed ID: 25145583 [TBL] [Abstract][Full Text] [Related]
9. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells. Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280 [TBL] [Abstract][Full Text] [Related]
11. Protein kinase C and P2Y12 take center stage in thrombin-mediated activation of mammalian target of rapamycin complex 1 in human platelets. Moore SF; Hunter RW; Hers I J Thromb Haemost; 2014 May; 12(5):748-60. PubMed ID: 24612393 [TBL] [Abstract][Full Text] [Related]
12. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes. Veilleux A; Houde VP; Bellmann K; Marette A Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102 [TBL] [Abstract][Full Text] [Related]
13. hCG activates Epac-Erk1/2 signaling regulating Progesterone Receptor expression and function in human endometrial stromal cells. Tapia-Pizarro A; Archiles S; Argandoña F; Valencia C; Zavaleta K; Cecilia Johnson M; González-Ramos R; Devoto L Mol Hum Reprod; 2017 Jun; 23(6):393-405. PubMed ID: 28333280 [TBL] [Abstract][Full Text] [Related]
14. Alkaline intracellular pH (pHi) increases PI3K activity to promote mTORC1 and mTORC2 signaling and function during growth factor limitation. Kazyken D; Lentz SI; Wadley M; Fingar DC J Biol Chem; 2023 Sep; 299(9):105097. PubMed ID: 37507012 [TBL] [Abstract][Full Text] [Related]
15. Determinants of rapamycin sensitivity in breast cancer cells. Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980 [TBL] [Abstract][Full Text] [Related]
16. S6K1 and 4E-BP1 are independent regulated and control cellular growth in bladder cancer. Nawroth R; Stellwagen F; Schulz WA; Stoehr R; Hartmann A; Krause BJ; Gschwend JE; Retz M PLoS One; 2011; 6(11):e27509. PubMed ID: 22110663 [TBL] [Abstract][Full Text] [Related]
17. HCG-mediated activation of mTORC1 signaling plays a crucial role in steroidogenesis in human granulosa lutein cells. Moravek MB; Shang M; Menon B; Menon K Endocrine; 2016 Oct; 54(1):217-224. PubMed ID: 27503318 [TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related]
19. Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Han S; Khuri FR; Roman J Cancer Res; 2006 Jan; 66(1):315-23. PubMed ID: 16397245 [TBL] [Abstract][Full Text] [Related]
20. cAMP-dependent activation of mammalian target of rapamycin (mTOR) in thyroid cells. Implication in mitogenesis and activation of CDK4. Blancquaert S; Wang L; Paternot S; Coulonval K; Dumont JE; Harris TE; Roger PP Mol Endocrinol; 2010 Jul; 24(7):1453-68. PubMed ID: 20484410 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]